Emergencies: Clinical Trials

47 trials for Emergencies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 7 recruiting, 5 unknown, 4 terminated. 47 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 347Completed 26, Recruiting 7, Unknown 5, Terminated 4, Not yet recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 26Completed 2, Unknown 2, Recruiting 1, Terminated 1

Follow Emergencies: new trials by email Literature Review of Emergencies trials Research Report on Emergencies

Trials (filtered) newest first · largest first

All 47 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Morphine or Ketamine for Analgesia
Ketamine hydrochloride, Morphine sulphate - Abdominal Pain, Isolated Extremity Fracture
Phase 3RecruitingColumbia University10102026-10-172026-10-20
Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department
20mg intranasal ketorolac, 30mg Intranasal Ketorolac - Pain, Ketorolac
Phase 3Not yet recruitingTehran University of Medical Sciences1002026-10-102026-09-16
Methoxyflurane Versus Usual Care for Non-Traumatic Pain in Emergency Departments
Analgesic management with Methoxyflurane as first-line treatment, Pain treatment according to the usual analgesic management protocol of the emergency department of the participating center. - Pain Management
Phase 3Not yet recruitingUniversity Hospital, Tours1642026-09-162026-08-03
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
Eptinezumab, Standard of Care - Migraine, Chronic Migraine
Phase 3Enrolling by invitationDr George Medvedev1022025-05-052026-09-30
Emergency Department-Initiated Medications for Alcohol Use Disorder
Naltrexone Pill, Naltrexone Injection, Brief Negotiation Interview - Alcohol Use Disorder
Phase 3RecruitingYale University2402024-08-172026-07-21
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Rivaroxaban 10 MG, Low Heparin Molecular Weight - Venous Thromboembolism, Deep Vein Thrombosis
Phase 3RecruitingUniversity Hospital, Angers14242024-07-192026-06-25
A Randomized Study Comparing of Three Doses Nebulized Fentanyl in Older Adults
Nebulized fentanyl - Treatment Side Effects, Musculoskeletal Pain
Phase 3CompletedBangkok Metropolitan Administration Medical College and Vajira Hospital1202024-07-012026-10-02
Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain
Ketorolac Tromethamine, Morphine Sulfate, normal saline - Acute Pain, Abdomen, Acute
Phase 3RecruitingUniversity of Calgary4952024-05-272024-06-24
Early Initiated Vasopressor Therapy in the Emergency Department
Noradrenaline - Shock, Shock, Septic
Phase 3RecruitingOdense University Hospital3202023-12-082025-07-01
Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation
Ketamine Hydrochloride, Normal saline - Suicidal Ideation
Phase 3UnknownUniversity of Ottawa202023-06-012023-02-13
Effect of Short-Term Prednisone Therapy on C-Reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers ( CORTAHF )
Prednisone arm, Usual care - Acute Heart Failure
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris32023-02-162026-01-21
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
Ketamine Hydrochloride, Crisis Response Plan - Suicide
Phase 2 / Phase 3RecruitingThe University of Texas Health Science Center at San Antonio242023-01-062026-09-30
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric], Ferrous Sulfate 65 mg elemental iron (325 mg tablets) - Anemia, Iron Deficiency, Uterine Bleeding
Phase 3RecruitingBaylor College of Medicine402022-09-152024-12-05
A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents
Ketorolac, Metoclopramide, Active Remote Electrical Neuromodulation Device - Migraine Disorders
Phase 3CompletedUniversity of Calgary222022-02-222025-03-12
Ketorolac for Moderate to Severe Abdominal Pain in Children
Ketorolac Tromethamine 10 MG/ML, Morphine Sulfate 10Mg/1mL Injection - Abdominal Pain, Appendicitis
Phase 3CompletedHamilton Health Sciences Corporation1052021-05-052023-02-28
Virginia Opioid Treatment-Emergency Department
SUBLOCADE - Opioid Use Disorder
Phase 3WithdrawnVirginia Commonwealth University2021-01-012021-02-12
IV Acetaminophen as Adjuvant Analgesic to Hydromorphone - Emergency Department Patients
IV acetaminophen, IV placebo, hydromorphone - Acute Pain
Phase 3CompletedAlbert Einstein College of Medicine1622018-11-272022-03-02
Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
Lidocaine, Placebo - Migraine
Phase 3UnknownNew York City Health and Hospitals Corporation502018-10-152021-01-05
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
Ibuprofen, Lidocaine Patch 4% - Acute Musculoskeletal Disease, Sprains
Phase 3CompletedEast Carolina University232018-06-232024-03-25
Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department
inhaled titration of morphine chlorhydrate, IV placebo, Inhaled placebo - Pain, Acute, Emergencies
Phase 3CompletedUniversity Hospital, Rouen2262017-09-192026-02-06

Showing 20 of 47. Sign in to see all of them.

Narrower conditions

Pain (8)  ·  Acute Pain (7)  ·  Agnosia (4)  ·  Migraine Disorders (4)  ·  Abdominal Pain (3)  ·  Asthma (3)  ·  Suicidal Ideation (3)  ·  Wounds and Injuries (3)  ·  Acute Coronary Syndrome (2)  ·  Alcoholism (2)  ·  Appendicitis (2)  ·  Depression (2)  ·  Gastroenteritis (2)  ·  Myocardial Infarction (2)

Broader conditions

Disease Attributes (47)  ·  Pathologic Processes (47)  ·  Pathological Conditions, Signs and Symptoms (47)  ·  Neurologic Manifestations (20)  ·  Signs and Symptoms (20)  ·  Nervous System Diseases (10)  ·  Pain (8)  ·  Behavior (7)  ·  Mental Disorders (6)  ·  Neurobehavioral Manifestations (6)  ·  Behavioral Symptoms (5)  ·  Cardiovascular Diseases (5)  ·  Chemically-Induced Disorders (5)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)

Interventions

Morphine (5)  ·  Hydromorphone (4)  ·  Ketamine (4)  ·  Saline Solution (4)  ·  Ketorolac Tromethamine (3)  ·  Sodium Chloride (3)  ·  Dexamethasone (2)  ·  Methoxyflurane (2)  ·  Standard of Care (2)  ·  Acetaminophen (1)  ·  Albuterol (1)  ·  Blood Specimen Collection (1)  ·  Budesonide (1)  ·  Budesonide, Formoterol Fumarate Drug Combination (1)  ·  Calcium Dobesilate (1)

Sponsors

Montefiore Medical Center (5)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  University of British Columbia (3)  ·  University Hospital, Rouen (2)  ·  University of Calgary (2)  ·  Albert Einstein College of Medicine (1)  ·  AstraZeneca (1)  ·  Bangkok Metropolitan Administration Medical College and Vajira Hospital (1)  ·  Baylor College of Medicine (1)  ·  Centre Hospitalier Annecy Genevois (1)  ·  Columbia University (1)  ·  Dr George Medvedev (1)  ·  East Carolina University (1)  ·  Geoffrey W Jara-Almonte (1)  ·  Hadassah Medical Organization (1)

Countries

United States (19)  ·  Canada (11)  ·  France (9)  ·  Denmark (1)  ·  Israel (1)  ·  Spain (1)  ·  Sweden (1)  ·  Thailand (1)  ·  Tunisia (1)

Top investigators

Mohamed Eltorki, MBChB (2)  ·  Alan Peterson, PhD, ABPP (1)  ·  Alan S Maisel, MD (1)  ·  Alberto Borobia, MD, PhD (1)  ·  Amy L Drendel, DO, MS (1)  ·  Andrew Chang, M.D. (1)  ·  Andrew K Chang, MD (1)  ·  Benjamin W Friedman, MD, MS (1)  ·  Benjamin W. Friedman, MD, MS (1)  ·  Brian Rowe, MD (1)  ·  Cheryl McCullumsmith, MD PhD (1)  ·  Christopher Kelly, MD (1)  ·  Daniel S Tsze, MD, MPH (1)  ·  Delphine Douillet, Doctor (1)  ·  Edward Bernstein, MD (1)

Results publications

PMID 10781906, PMID 10894454, PMID 11459715, PMID 12615585, PMID 17059854, PMID 17371409, PMID 17898251, PMID 18503626, PMID 18837637, PMID 20030425, PMID 20370749, PMID 21216272, PMID 22424002, PMID 22830462, PMID 23442240, PMID 23685743, PMID 24403618, PMID 24560834, PMID 25027194, PMID 25043629, PMID 25125300, PMID 25710925, PMID 25819865, PMID 26476506, PMID 26762723, PMID 27006119, PMID 27413071, PMID 28487318, PMID 28923845, PMID 29138794, PMID 30354493, PMID 30405295, PMID 30786094, PMID 30975187, PMID 31623936, PMID 33583341, PMID 33766254, PMID 34273095, PMID 35146776, PMID 35348606, PMID 35383071, PMID 35558868, PMID 37139824, PMID 38001050, PMID 38969374, PMID 39290050, PMID 42782131, PMID 8324412, PMID 8867257, PMID 9311623

NIH funding

2023 (2), 2009 (1), 2025 (1), R01AA030568 (1), R21AA015123 (1), U01HD116253 (1), UL1TR002645 (1)